Immunizations

In this April 2014 photo provided by the Vaccine and Infectious Disease Organization-International Vaccine Centre at the University of Saskatchewan, a researcher holds a ferret at their facility in Saskatoon, Saskatchewan, Canada. In 2020, the lab is working with 300 ferrets developing a COVID-19 coronavirus vaccine candidate and testing other vaccine candidates and therapeutics. (VIDO-InterVac at the University of Saskatchewan via AP)
June 02, 2020 - 5:29 am
The global race for a COVID-19 vaccine boils down to some critical questions: How much must the shots rev up someone’s immune system to really work? And could revving it the wrong way cause harm? Even as companies recruit tens of thousands of people for larger vaccine studies this summer, behind...
Read More
FILE - In this Oct. 28, 2018, file photo, then-Washington Redskins running back Chris Thompson (25) warms up before an NFL football game against the New York Giants in East Rutherford, N.J. Reporters from The Associated Press spoke to more than two dozen athletes from around the globe -- representing seven countries and 11 sports -- to get a sense of how concerned or confident they are about resuming competition. Thompson is an NFL running back. He’s also the father of a 4-month-old daughter, Kali. “If I go practice or play and I come back home with the virus, she’s not strong enough yet to fight something like that. For me, that’s my biggest worry,” said Thompson, who signed with the Jacksonville Jaguars this month after seven seasons with the Redskins. (AP Photo/Seth Wenig, File)
May 28, 2020 - 2:54 pm
Chris Thompson is an NFL running back. He also is the father of a 4-month-old daughter, Kali. Guess which of those facts matters more to him when he ponders eventually returning to work amid a pandemic. “If I go practice or play and I come back home with the virus ... that’s my biggest worry,” said...
Read More
FILE - In this April 22, 2020, file photo, pallbearers, who were among only 10 allowed mourners, walk the casket for internment at the funeral for Larry Hammond, who died from the coronavirus, at Mount Olivet Cemetery in New Orleans. Hammond was Mardi Gras royalty, and would have had hundreds of people marching behind his casket in second-line parades. (AP Photo/Gerald Herbert, File)
AP News
May 27, 2020 - 8:16 pm
HARTFORD, Conn. (AP) — The U.S. surpassed a jarring milestone Wednesday in the coronavirus pandemic: 100,000 deaths. That number is the best estimate and most assuredly an undercount. But it represents the stark reality that more Americans have died from the virus than from the Vietnam and Korean...
Read More
This May 4, 2020 photo from the University of Maryland School of Medicine, the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore, receives an injection. Only about half of Americans say they would get a COVID-19 vaccine if the scientists working furiously to create one succeed, according to a poll conducted May 14-18 by The Associated Press-NORC Center for Public Affairs Research. (University of Maryland School of Medicine via AP)
May 27, 2020 - 9:47 am
Only about half of Americans say they would get a COVID-19 vaccine if the scientists working furiously to create one succeed, according to a new poll from The Associated Press-NORC Center for Public Affairs Research. That’s surprisingly low considering the effort going into the global race for a...
Read More
May 27, 2020 - 1:32 am
WASHINGTON, D.C. (AP) — AP-NORC poll: About half of Americans would get a COVID-19 vaccine if they could, while many are unsure or would refuse.
Read More
May 25, 2020 - 8:35 pm
CANBERRA, Australia (AP) — A U.S. biotechnology company began injecting a coronavirus vaccine candidate into people in Australia on Tuesday with hopes of releasing a proven vaccine this year. Novavax will inject 131 volunteers in the first phase of the trial testing the safety of the vaccine and...
Read More
FILE - In this Sunday, Aug. 28, 2016 file photo, a health official administers a polio vaccine to children at a camp for people displaced by Islamist Extremist in Maiduguri, Nigeria. The coronavirus pandemic is interrupting immunization against diseases including measles, polio and cholera that could put the lives of nearly 80 million children at risk, according to a new analysis on Friday May 22, 2020, from the World Health Organization and partners. (AP Photo/Sunday Alamba, File)
May 22, 2020 - 1:53 pm
LONDON (AP) — The coronavirus pandemic is interrupting immunization against diseases including measles, polio and cholera that could put the lives of nearly 80 million children under the age of 1 at risk, according to a new analysis from the World Health Organization and partners. In a new report...
Read More
FILE - In this Thursday, Feb. 20, 2020 file photo, a view of the AstraZeneca logo, on a building, in South San Francisco, Calif. Drug maker AstraZeneca secured its first agreements Thursday, May 21, 2020 for 400 million doses of a COVID-19 vaccine, bolstered by an investment from the U.S. vaccine agency. (AP Photo/Jeff Chiu, File)
May 22, 2020 - 11:37 am
LONDON (AP) — British researchers testing an experimental vaccine against the new coronavirus are moving into advanced studies and aim to immunize more than 10,000 people to determine if the shot works. Friday’s announcement came as Chinese scientists who are developing a similar vaccine reported...
Read More
Kevin Gonzales, director of operations at the Rajen Kilachand Center for Integrated Life Sciences and Engineering, at Boston University, places safe distancing floor markings near an elevator on the school's campus, in Boston, Thursday, May 21, 2020. Boston University is among a growing number of universities making plans to bring students back to campus this fall, but with new measures meant to keep the coronavirus at bay. (AP Photo/Steven Senne)
AP News
May 21, 2020 - 2:08 pm
Growing numbers of U.S. colleges are pledging to reopen this fall, with dramatic changes to campus life to keep the coronavirus at bay. Big lectures will be a thing of the past. Dorms will will be nowhere near capacity. Students will face mandatory virus testing. And at some smaller schools,...
Read More
FILE - In this Thursday, Feb. 20, 2020 file photo, a view of the AstraZeneca logo, on a building, in South San Francisco, Calif. Drug maker AstraZeneca secured its first agreements Thursday, May 21, 2020 for 400 million doses of a COVID-19 vaccine, bolstered by an investment from the U.S. vaccine agency. (AP Photo/Jeff Chiu, File)
May 21, 2020 - 12:59 pm
LONDON (AP) — Drug maker AstraZeneca said Thursday it had secured its first agreements for 400 million doses of a COVID-19 vaccine it is testing, bolstered by an investment from the U.S. vaccine agency. The Anglo-Swedish company reported it had received more than $1 billion from the U.S. Biomedical...
Read More

Pages